148 related articles for article (PubMed ID: 25061743)
1. Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review.
Lu XX; Zhu LQ; Pang F; Sun W; Ou C; Li Y; Cao J; Hu YL
Genet Mol Res; 2014 Jul; 13(3):5182-9. PubMed ID: 25061743
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 promoter methylation correlation with pathogenesis of hepatocellular carcinoma in Asians.
Lu W; Liu Y; Liu LL; Zhuang PH
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420934
[TBL] [Abstract][Full Text] [Related]
3. Methylation of tumour suppressor genes
El-Bendary M; Nour D; Arafa M; Neamatallah M
Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
[No Abstract] [Full Text] [Related]
4. Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.
Yang Y; Ye Z; Zou Z; Xiao G; Luo G; Yang H
Tumour Biol; 2014 Oct; 35(10):10333-40. PubMed ID: 25037468
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
Zhang X; He H; Zhang X; Guo W; Wang Y
Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
[TBL] [Abstract][Full Text] [Related]
6. Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.
Sun G; Zhang C; Feng M; Liu W; Xie H; Qin Q; Zhao E; Wan L
Medicine (Baltimore); 2017 Oct; 96(41):e8279. PubMed ID: 29019900
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
8. Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.
Poungpairoj P; Whongsiri P; Suwannasin S; Khlaiphuengsin A; Tangkijvanich P; Boonla C
Asian Pac J Cancer Prev; 2015; 16(13):5343-8. PubMed ID: 26225676
[TBL] [Abstract][Full Text] [Related]
9. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
Lv X; Ye G; Zhang X; Huang T
Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
[TBL] [Abstract][Full Text] [Related]
10. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
Zheng Y; Hlady RA; Joyce BT; Robertson KD; He C; Nannini DR; Kibbe WA; Achenbach CJ; Murphy RL; Roberts LR; Hou L
Clin Epigenetics; 2019 Oct; 11(1):145. PubMed ID: 31639042
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
[TBL] [Abstract][Full Text] [Related]
13. [Expression of RUNX3 protein in hepatic cell carcinoma and its clinicopathological implications].
Lu YH; Zheng RD; Chen J; Chen BF; Li JG; Lin ZC
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):329-32. PubMed ID: 21354923
[TBL] [Abstract][Full Text] [Related]
14. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
[TBL] [Abstract][Full Text] [Related]
15. Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis.
Fan XY; Hu XL; Han TM; Wang NN; Zhu YM; Hu W; Ma ZH; Zhang CJ; Xu X; Ye ZY; Han CM; Pan WS
BMC Gastroenterol; 2011 Aug; 11():92. PubMed ID: 21867527
[TBL] [Abstract][Full Text] [Related]
16. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.
Shiraha H; Nishina S; Yamamoto K
J Cell Biochem; 2011 Mar; 112(3):745-9. PubMed ID: 21328447
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
18. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
Li YS; Xie Q; Yang DY; Zheng Y
Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
[TBL] [Abstract][Full Text] [Related]
19. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
Liu M; Cui LH; Li CC; Zhang L
Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
[TBL] [Abstract][Full Text] [Related]
20. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
Nakanishi Y; Shiraha H; Nishina S; Tanaka S; Matsubara M; Horiguchi S; Iwamuro M; Takaoka N; Uemura M; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
BMC Cancer; 2011 Jan; 11():3. PubMed ID: 21205319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
